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The Haemophilus ducreyi outer membrane component DsrA (for ducreyi serum resistance A) is necessary for
complete resistance to normal human serum (NHS). When DsrA expression in 19 temporally and geograph-
ically diverse clinical isolates of H. ducreyi was examined by Western blotting, 5 of the strains expressed a
different immunotype of the DsrA protein (DsrAII) than the well-characterized prototypical strain 35000HP
(DsrAI). The predicted DsrA proteins expressed by the DsrAII strains were 100% identical to each other but
only 48% identical to that of strain 35000HP. In addition to the DsrAII protein, class II strains also expressed
variant forms of other outer membrane proteins (OMPs) including NcaA (necessary for collagen adhesion A),
DltA (ducreyi lectin A), Hlp (H. ducreyi lipoprotein), major OMP, and/or OmpA2 (for OMP A2) and synthe-
sized a distinct, faster-migrating lipooligosaccharide. Based on these data, strains expressing DsrAI were
termed class I, and those expressing DsrAII were termed class II. Expression of dsrAII from strain CIP 542
ATCC in the class I dsrAI mutant FX517 (35000HP background), which does not express a DsrA protein,
rendered this strain resistant to 50% NHS. This demonstrates that DsrAII protein is also critical to serum
resistance. Taken together, these results indicate that there are two clonal populations of H. ducreyi. The
implications of two classes of H. ducreyi strains differing in important antigenic outer membrane components
are discussed.
Haemophilus ducreyi is a gram-negative, strict human patho-
gen and the etiologic agent of the sexually transmitted genital
ulcer disease chancroid. Chancroid occurs more commonly in
certain areas of Africa, Asia, and Latin America (8, 55, 69)
than in the United States (17, 36). Regardless of the socioeco-
nomic conditions where chancroid occurs, underreporting and
misdiagnosis make accurate predictions of the prevalence of
chancroid difficult (36). The focus on chancroid has intensified
because it increases the risk for transmission and acquisition of
the human immunodeficiency virus (29, 32, 55). Control of
chancroid may result in a decrease in the spread of human
immunodeficiency virus.
Chancroid is thought to initiate upon the entry of H. ducreyi
into the skin through small abrasions that occur during sexual
intercourse (37). Small tender papules form at the site of entry
within 2 to 7 days of acquisition. The papules evolve into
pustules, that rupture within 2 to 3 days to form soft painful
ulcers. The ulcers persist for several weeks to months but may
ultimately resolve (37).
The study of chancroid pathogenesis has lead to the identi-
fication of a number of H. ducreyi antigens that may be impor-
tant for the production of disease (4, 11, 12, 18, 19, 25, 31, 33,
35, 39, 45, 50, 54, 65, 67, 71, 72). Thus far, few cell surface
determinants, including full-length lipooligosaccharide (LOS),
have been shown to be essential for H. ducreyi infection in the
human model of chancroid (5, 9, 22, 28, 56). Included among
these virulence factors is the protein termed DsrA (for ducreyi
serum resistance A), which has been shown to be responsible
for serum resistance (19), keratinocyte cell adhesion (14), and
binding to the extracellular matrix protein (ECM) vitronectin
(14).
DsrA (19) is a member of the Oca (for oligomeric coiled
adhesin) family, a group of surface-exposed multifunctional
proteins involved in binding to cells and to the ECM and
resistance to killing by serum complement (27, 48). This family
of proteins includes the Yersinia adhesin YadA (47, 53, 62)
found in pathogenic Yersinia species; the ubiquitous surface
proteins of Moraxella catarrhalis, UspA1 and UspA2 (1, 2); the
NadA proteins of meningococci (16); and the Eib proteins of
Escherichia coli (48, 49). Very recently, Cole et al. (15) de-
scribed a second H. ducreyi Oca family member termed NcaA
(for necessary for collagen adhesion A). Hoiczyk et al. (27)
proposed that YadA and UspA are capable of forming highly
structured oligomers, resulting in so-called lollipop-shaped
structures on the cell surface. These structures are thought to
be composed of an N-terminal head domain, an intermediate
central stalk domain, and a conserved C-terminal anchoring
domain. The C-terminal domain of YadA has been shown to
be sufficient to grant serum resistance (46), whereas the N-
terminal domain confers binding to ECMs such as fibronectin
(63) and collagen (CN) (21, 52).
In the course of immunoblot studies with anti-DsrA anti-
bodies, we discovered that a monoclonal antibody (MAb) to
35000HP DsrA failed to bind H. ducreyi strains CIP 542 ATCC
and HMC112, even though a polyclonal antiserum made to the
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35000HP DsrA antigen was reactive to these strains. We sur-
mised that there could be important antigenic differences be-
tween the DsrA proteins from strains CIP 542 ATCC,
HMC112, and 35000HP. The objectives of this study were
therefore to determine if the DsrA proteins from these strains
were different at the nucleotide and amino acid levels, if both
types of DsrA possessed the same function in H. ducreyi, and if
these strains also expressed different types of other outer mem-
brane determinants.
MATERIALS AND METHODS
Strains and media. Bacterial strains and plasmids used in this study are listed
in Tables 1 and 2.
H. ducreyi strains were maintained on chocolate agar plates containing 1
GGC (0.1% glucose, 0.01% glutamine, and 0.026% cysteine) (68) and 5% fetal
bovine serum (Sigma, St. Louis, Mo.) at 34.5°C in 5% CO2. E. coli was grown in
Luria-Bertani broth or on Luria-Bertani agar plates at 37°C. When appropriate,
streptomycin (100 g/ml), chloramphenicol (1 g/ml for H. ducreyi and 30 g/ml
for E. coli), kanamycin (30 g/ml), or ampicillin (100 g/ml) was incorporated
into the media.
Serum susceptibility. H. ducreyi resistance to 50% normal human serum
(NHS) was determined as previously described (13, 19, 33, 41) except that H.
ducreyi cultures were grown on chocolate agar plates containing 5% fetal bovine
serum. Data are expressed as percent survival in fresh NHS compared to survival
in heated NHS (NHS) [(CFU in fresh NHS/CFU in NHS)  100].
Western blotting. H. ducreyi total proteins from approximately 0.5  107 CFU
were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) under reducing conditions, transferred to a nitrocellulose mem-
brane, and subjected to Western blotting as previously described (33).
Dot blot. H. ducreyi cells were suspended in phosphate-buffered saline to an
optical density at 600 nm of 0.2 and suctioned onto a nitrocellulose membrane
with a dot blot apparatus (Schleicher & Schuell, Keene, N.H.). The membrane
was removed from the dot blot apparatus, allowed to dry at room temperature,
and blocked for 30 min in 5% skim milk. The membrane was reassembled into
the dot blot apparatus, and the following primary antibodies were added to the
wells at the given concentrations (in parentheses): anti-recombinant N-terminal
DsrAI (anti-rNT-DsrAI) (1:10), anti-rNT-DsrAII (1:200), and anti-outer mem-
brane proteins (anti-OMPs) (1:200) (24). The membrane was incubated at room
temperature for 1 h with gentle shaking. Wells were washed four times (high-salt
wash buffer of 20 mM Tris and 500 mM NaCl) prior to incubation with alkaline
phosphatase-conjugated protein G (1:200) for 45 min with gentle shaking. Fi-
nally, the membrane was washed twice, removed from the dot blot apparatus,
and washed a third time before addition of the chemiluminescence substrate for
development (Lumi-PhosWB; Pierce, Rockford, Ill.).
Analysis of LOS. Approximately 4  108 CFU (optical density at 600 nm, 0.4)
were suspended in 200 l of Laemmli sample buffer and incubated with protein-
ase K (final concentration, 50 g/ml) for 1 h at 56°C (26). The preparation was
boiled for 1 min and stored at 4°C. Approximately 5 l of this preparation was
subjected to SDS-PAGE and silver stained according to the method of Tsai and
Frasch (70).
Cloning, sequencing, and mutagenesis of dsrAII from strain CIP 542 ATCC.
To mutagenize dsrAII from strains CIP 542 ATCC and HMC112, a class II
specific mutagenesis plasmid, pUNCH 1292, was constructed. Primers that am-
plified class I dsrA did not work for class II strains. It was assumed that genes
flanking dsrA were conserved between classes, and the genome sequence of
strain 35000HP (www.stdgen.lanl.gov) to design primers flanking the dsrA open
reading frame (ORF) was used. Using primer 33 located within the upstream
manX (HD0768) gene and primer 24 (Fig. 1 and Table 4) at 10 pmol each, we
amplified approximately 2.5 kb of DNA from several colonies of strain HMC112
and CIP 542 ATCC. We used Ready to Go PCR beads (Amersham Biosciences,
Piscataway, N.J.) according to the manufacturer’s instructions. The PCR condi-
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant genotype and/or phenotypea Source or reference
Strains
E. coli
DH5MCR recA gyrB Bethesda Research Laboratories
BL21(DE3)pLysS Expression of hexahistidine tag fusion proteins; Cmr Invitrogen; 61
H. ducreyi
35000HP Wild type, parent, class I Stanley Spinola, Indiana University
CIP 542 ATCC Wild type, parent, class II American Type Culture Collection
HMC112 Wild type, parent, class II P. Totten, University of Washington
Plasmids
pCRT7/CT-TOPO Expression vector; Ampr Invitrogen
pCRT2.1TOPO/TA Cloning vector; Ampr Invitrogen
pLSKS Shuttle vector; replicates in H. ducreyi and E. coli; Smr Cmr 73
pRSM1791 Mutagenesis vector; -Galactosidase Ampr 10
pNC40 Source of CAT cassette; Ampr Cmr 64
pUC4K Source of APT cassette; Kmr Ampr Pharmacia
pUNCH 1250 dsrAI-pET30a plasmid (35000HP); Amp
r 14
pUNCH 1260 dsrAI-pLSKS plasmid (35000HP); Cm
r Smr 19
pUNCH 1272 ncaAI-pCR2.1TOPO/TA, (35000HP) Amp
r This study
pUNCH 1274 ncaAI::CAT-pCR2.1 TOPO/TA plasmid (35000HP); Cm
r This study
pUNCH 1275 ncaAI::CAT-pRSM1791 (35000HP); Cm
r This study
pUNCH 1288 dsrAII-pLSKS plasmid (CIP 542 ATCC); Cm
r Smr This study
pUNCH 1291 dsrAII::CAT-pLSKS plasmid (CIP 542 ATCC); Cm
r Smr This study
pUNCH 1292 dsrAII::CAT-pRS M1791 plasmid (CIP 542 ATCC); Cm
r This study
pUNCH 1293 dsrAI-pCRT7/CT-TOPO plasmid (35000HP); Amp
r This study
pUNCH 1294 dsrAII-pCRT7/CT-TOPO plasmid (CIP 542 ATCC); Amp
r This study
pUNCH 1295 ncaAI-pCRT7/CT-TOPO plasmid (35000HP); Amp
r This study
pUNCH 1296 dsrAII-pLSKS plasmid (CIP 542 ATCC); Cm
r Smr This study
pUNCH 1297 ncaA::KAN-pCR2.1TOPO/TA plasmid; Kmr This study
pUNCH 1298 ncaA::KAN-pRSM1791 plasmid; Kmr This study
a CAT, chloramphenicol acetyltransferase; APT, aminoglycoside 3-phosphotransferase.
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tions were a single denaturation at 95°C for 1 min and 30 cycles, each consisting
of 1-min denaturation at 95°C, annealing at 52°C for 1 min, and extension at 72°C
for 2 min. Following amplification, the product was digested with XbaI and
HindIII overnight and ligated to XbaI- and HindIII-digested pLSKS vector to
construct pUNCH 1288. Plasmid pUNCH 1288 was digested with StuI and
ligated to the BglII- and Klenow-treated chloramphenicol acetyltransferase cas-
sette from plasmid pNC40 to form pUNCH 1291. The mutagenized dsrAII insert
was removed by digesting pUNCH 1291 with SmaI and XhoI prior to Klenow
treatment. The insert was then ligated to NotI- and Klenow-treated mutagenesis
vector pRSM1791 to form pUNCH 1292. pUNCH 1292 was then electroporated
into CIP 542 ATCC and HMC112. However, we were unable to recover Cm-
resistant putative cointegrates in either strain CIP 542 ATCC or HMC112 by this
FIG. 1. Diagram of class I and class II dsrA genes and PCR products. The dsrA ORF is boxed. The partial manX ORF is represented by an
open box with a jagged line at the upstream end; the partial HD0770 ORF is represented by an open box with a jagged line at the downstream
end. The numbered arrows indicate the direction and position of the dsrA oligonucleotides used for PCR. The proposed signal sequence (ss) is
indicated by a shaded box. Curved arrows indicate the polarity of each gene. (A) The PCR products used to construct plasmids pUNCH 1260 and
pUNCH 1296 are indicated. (B) The dsrA PCR products are represented by a solid black line followed by a hexahistidine fusion tag depicted by
an open box. The PCR-His fusion products were used to produce expression plasmids pUNCH 1250, pUNCH 1293, and pUNCH 1294. Strains
and vectors used for PCR are specified to the left of the PCR product. his, hexahistidine, composed of 30 amino acids; P, promoter.
TABLE 2. Panel of H. ducreyi strains used in experiments shown in Fig. 4
Strain Other name Geographic site ofisolation
Yr of
isolation Source (reference)
35000HP Winnipeg 1975 S. Spinola (58)
HMC46 1023 Kenya 1995 P. Totten
HMC48 M90-02 Bahamas 1995 P. Totten (73)
HMC50 425 Jackson, Miss. 1995 P. Totten (73)
HMC54 010-2 Dominican Republic 1995 P. Totten (73)
HMC56 UG030 Dominican Republic 1995 P. Totten (73)
HMC60 HD174 Florida 1989 P. Totten (73)
HMC62 HD301 Thailand 1984 P. Totten (73)
HMC64 HD350 Kenya 1984 P. Totten (73)
HMC88 H1-95 Seattle 1995 P. Totten (73)
DMC188 Bangladesh J. Boegarts (this study)
SSMC57 Bangladesh J. Boegarts (this study)
26V Atlanta W. Albritton (18)
C111 Nairobi W. Albritton (18)
CIP 542 ATCC Hanoi, Vietnam 1954 American Type Culture Collection
DMC64 Bangladesh J. Boegarts, this study
DMC111 Bangladesh J. Boegarts, this study
SSMC71 Bangladesh J. Boegarts, this study
HMC112 HD342 CDC 1984 P. Totten
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method on several occasions. Therefore, to study DsrAII function, we cloned and
expressed dsrAII in trans in the dsrAI mutant FX517 (19).
To clone dsrAII, CIP 542 ATCC whole cells were used as a template and
subjected to PCR as described above. dsrAII-specific primers, dsrA 42 and dsrA
43 (Table 4), were constructed from the sequence of dsrAII in pUNCH 1288.
Following amplification, the approximately 1.3-kb product was restricted with
XbaI and HindIII overnight. The dsrAII PCR product was ligated to XbaI- and
HindIII-digested pLSKS vector to produce pUNCH 1296. This clone is equiva-
lent to the pUNCH 1260 dsrAI plasmid in the amount of flanking sequences (Fig.
1). With the dsrAII PCR product as template, the dsrAII ORF and promoter
region were completely sequenced on both strands with strain-specific primers
dsrA 42 and dsrA 43. The ligation product was then electroporated into FX517.
Restriction analysis and Western blotting with anti-rNt-DsrAII sera confirmed
the transformants (data not shown). Since DsrA class I and class II strains share
similar C termini, transformants expressing DsrAII were also recognized by
polyclonal antirecombinant full-length DsrAI (rFL-DsrAI) antisera (see below).
Identification of ncaAII. Primers ncaA 0.08 and ncaA 0.09, which had been
used to successfully amplify ncaAI from strain 35000HP, failed to amplify a
product from class II H. ducreyi strains. Since ncaAI in strain 35000HP is located
between recG, which encodes an ATP-dependent DNA helicase, and proS, which
encodes a prolyl-tRNA synthetase (www.stdgen.lanl.gov), we presumed that
these flanking genes would be conserved in the dsrA class II strains. Therefore,
we designed primers ncaA 0.10 and ncaA 0.11 (Table 4), located 750 bp upstream
of the ncaA 0.08 primer site and 978 bp downstream of the ncaA 0.09 primer site,
respectively. PCR conditions were the same as described for dsrAII, with the
exception of a final magnesium concentration of 2.5 mM, 20 pmol of each
primer, and an annealing temperature of 50°C. A 2.2-kb PCR product was
amplified from all class II strains and sequenced.
PCR and sequencing of class I and class II hemoglobin receptor A genes (hgbA
genes). To PCR amplify hgbA from H. ducreyi strains, whole cells were used as
a template and subjected to PCR as described for dsrAII with the following
exceptions: 30 cycles, each consisting of 1-min denaturation at 95°C, annealing at
58°C for 1 min, and extension at 72°C for 3.5 min; and a final cycle of 95°C for
1 min, 58°C for 1 min, and 72°C for 5 min. A 3.3-kb product was predicted with
primers hgbA-F and hgbA-R (Table 4), and a product of approximately 3.3 kb was
obtained. The hgbA ORF was completely sequenced on both strands with the
PCR product as a template and primers hgbA-F and hgbA-R (Table 4).
Cloning of rNt DsrAI, DsrAII, and NcaAI. To generate class-specific antisera to
the mature N-terminal two-thirds of recombinant DsrAI and DsrAII, expression
plasmids were constructed by cloning the N-terminal variable regions of the dsrA
gene of strains 35000HP and CIP 542 ATCC in a vector containing a C-terminal
hexahistidine tag (Fig. 1). Primers dsrA 38 and dsrA 39 were used for strain
35000HP, and dsrA 36 and dsrA 37 were used for CIP 542 ATCC (Fig. 1; Table
4). Conditions for PCR were the same as those described for dsrAII. Products of
approximately 0.5 and 0.6 kb were generated for strains 35000HP and CIP 542
ATCC, respectively. Products were ligated to pCRT7/CT-TOPO vector (Invitro-
gen, Carlsbad, Calif.) and transformed into E. coli DH5 MCR. Plasmid DNA
was isolated from the pool of DH5 transformants and electroporated into E.
coli BL21(DE3)pLysS. Transformants were screened by Western blotting with
anti-rFL-DsrAI (14), following induction with isopropyl--D-thiogalactoside
(IPTG). Positive clones expressed an approximately 21-kDa protein (expressed
by dsrAI from 35000HP) or an approximately 24 kDa protein (expressed by dsrAII
from strain CIP 542 ATCC). A single transformant from positive 35000HP and
CIP 542 ATCC clones was chosen for each and termed pUNCH 1293 (35000HP)
and pUNCH 1294 (CIP 542 ATCC), respectively.
The specific N-terminal sequence encoding NcaAI (Fig. 5) was PCR amplified
from strain 35000HP with primers ncaA 0.08 and ncaA 0.09 (Table 4) as de-
scribed above. The PCR fragment was ligated to the pCRT7/CT-TOPO vector,
clones were identified as described above, and a single one was termed pUNCH
1295.
Purification of recombinant protein for immunization purposes. One-liter
cultures of pUNCH 1293 (dsrAI), pUNCH 1294 (dsrAII), and pUNCH 1295
(ncaAI) in BL21(DE3)pLysS were grown in liquid broth with appropriate anti-
biotics (Table 1). As previously described (14, 44), protein expression was in-
duced from these plasmids with IPTG. The cultures were subsequently treated
with rifampin to inhibit bacterial RNA polymerase. Inclusion bodies were iso-
lated and washed extensively until the recombinant protein was 95% pure (data
not shown).
Production of specific recombinant DsrAI, DsrAII, NcaAI, and HgbAI antibod-
ies. Antibodies used in this study are listed in Table 3. Female New Zealand
White rabbits (Covance, Denver, Pa.) were immunized a total of four times by
administration of 200 g of rNt-DsrAI, rNt-DsrAII, rNt-NcaAII, or rFL-HgbAI
(20) protein every 2 weeks. Freund’s complete adjuvant was used for the initial
immunization, whereas successive immunizations were in incomplete Freund’s
adjuvant. Sera were collected prior to the first immunization and 2 weeks fol-
lowing the final immunization.
Production of MAbs. MAbs were obtained as described by Patterson et al.
(44), except that 5 g of rFL-DsrAI protein (Table 3) (14) from strain 35000HP
was used as the immunogen. The SBA Clonotyping System/AP (Southern Bio-
tech, Birmingham, Ala.) was used to isotype antibodies from established murine
hybridomas.
Protein alignments and analysis. PRETTY BOX and BESTFIT (GCG Com-
puter Group, Wisconsin) were used to generate protein lineups and similarity
and identity scores (with a gap weight of 8) (Fig. 3 and 5). Possible signal
peptidase I cleavage sites were predicted with LipoP 1.0 (Center for Biological
Sequence Analysis, Lyngby, Denmark [www.cbs.dtu.dk/services]) (30).
Nucleotide sequence accession numbers. Relevant DNA and deduced amino
acid sequences have been submitted to GenBank, and accession numbers are
listed in Table 5.
RESULTS
Identification of a novel antigenically variant class of DsrA
protein. Routine examination of a polyclonal antibody made to
the full-length, mature recombinant DsrA protein from
35000HP, rFL-DsrAI, showed that it bound to an approxi-
mately 30-kDa protein in strains HMC112 and CIP 542 ATCC
in a Western blot (Fig. 2A, panel 1). We therefore hypothe-
sized that the 30-kDa protein found in CIP 542 ATCC and
HMC112 was also DsrA. However, the protein in strains CIP
542 ATCC and HMC112 was not recognized by MAb 4.79, also
developed to rFL-DsrAI (Fig. 2A, panel 2), and migrated
slightly more slowly than the DsrA from strain 35000HP (Fig.
TABLE 3. Antibodies used in this study
Name Recombinant protein used as immunogen Reference
Polyclonal antibodies (rabbit)
Anti-rFL-DsrAI Mature full-length DsrA, strain 35000HP (class I), pUNCH 1250
a 14
Anti-rFL-DltAI Mature full-length DltA, strain 35000HP (class I), pUNCH 1286 33
Anti-rFL-HgbAI Mature full-length HgbA, strain 35000HP (class I), pUNCH 572 20
Anti-rFL-HlpI Mature full-length HlpA, strain 35000HP (class I) 25
Anti-rNt-DsrAI N-terminal DsrA, strain 35000HP (class I), pUNCH 1293 This study
Anti-rNt-DsrAII N-terminal DsrA, strain CIP 542 ATCC (class II), pUNCH 1294 This study
Anti-rNt-NcaAI N-terminal NcaA, strain 35000HP (class I), pUNCH 1295 This study
Anti-Omp Outer membrane preparation, strain 35000HP (class I) 24
MAbs (Mouse)
4.79 Mature full-length DsrA, strain 35000HP (class I); pUNCH 1250 This study
2C7 H. influenzae biogroup aegyptius 34, 57
a Subsequent to this publication, we found an error in the primer used to construct clone pUNCH 1250 that would result in a single amino acid change, A249G.
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2A, panel 1). This suggested that the DsrA protein from strains
CIP 542 ATCC and HMC112 may be antigenicly different than
that of strain 35000HP. For the purpose of this communica-
tion, we designated the DsrA from 35000HP DsrAI; DsrA
from CIP 542 ATCC and HMC112 was designated DsrAII. We
chose strain CIP 542 ATCC as the type strain for DsrAII-
expressing strains.
To determine if the 30-kDa protein in strain CIP 542 ATCC
was DsrA, we attempted to construct an isogenic dsrA mutant
of CIP 542 ATCC but were unsuccessful (described in Mate-
rials and Methods). As an alternative to testing DsrA expres-
sion and function in an isogenic mutant, we constructed plas-
mid pUNCH 1296 (dsrAII from CIP 542 ATCC) and expressed
it in host strain FX517 (Table 1), a 35000HP dsrAI isogenic
mutant. Like parent strains 35000HP and CIP 542 ATCC,
FX517 expressing dsrAI from plasmid pUNCH 1260 or dsrAII
from pUNCH 1296 was bound by rFL-DsrAI antibody (Fig.
2A, panel 1), while the MAb 4.79 only bound to FX517 ex-
pressing dsrAI (Fig. 2A, panel 2). Neither antibody bound
strain FX517 harboring the empty vector pLSKS.
DsrAI was previously shown to be expressed at the surface of
H. ducreyi cells (19). To determine if DsrAII was also surface
exposed, H. ducreyi strains were examined in a whole-cell dot
blot with anti-rDsrA and anti-OMP antibodies. H. ducreyi par-
ent strains 35000HP, CIP 542 ATCC, and HMC112, as well as
the dsrAI mutant strain FX517 expressing either class of dsrA
or harboring an empty vector, were studied. Anti-rNt-DsrAI,
specific for DsrAI, bound whole cells of 35000HP and
FX517pUNCH 1260 (dsrAI), while anti-rNt-DsrAII, specific to
the DsrAII protein, bound strains CIP 542 ATCC, HMC112,
and FX517pUNCH 1296 (dsrAII) (Fig. 2B). Anti-OMP, a pos-
itive control antibody to the OMPs of H. ducreyi strain
35000HP (24), bound all strains tested, although it bound class
II strains less strongly. Thus, DsrAII is expressed at the surface
of H. ducreyi cells.
DNA sequence and deduced amino acid sequence of the H.
ducreyi dsrAII locus from strain CIP 542 ATCC. Since a poly-
clonal antibody to DsrAI bound to DsrAII from strains CIP 542
ATCC and HMC112 in a Western blot but MAb 4.79 did not,
we predicted that there were both antigenically conserved and
unique epitopes in the DsrA proteins of the two strain classes.
Initial attempts to amplify dsrAII in class II strains using prim-
ers 14 and 24, previously used to amplify dsrA from 35000HP
and eight other strains of H. ducreyi (19), were unsuccessful
(Fig. 1). However, successful amplification occurred using
primers 33 (located 975 bp upstream of the 35000HP dsrA start
codon) and 24 (277 bp downstream of the dsrA stop codon).
An approximately 2.5-kb PCR product was observed from CIP
542 ATCC (Fig. 1). The sequence of the dsrAII locus and 1,621
bp of flanking DNA (Table 5) were obtained from the PCR
products. Putative promoter elements similar to the 	35 (TT
GACA) and 	10 (TAGAAT) sites of dsrA from 35000HP
were located 74 nucleotides (nt) (TTGACT) and 50 nt
(TATAAT) upstream of the start codon, respectively, and sep-
arated by 18 nt. The manX (HD0768) gene, encoding a com-
ponent of a putative mannose-specific uptake system (www
.stdgen.lanl.gov), was located upstream of dsrA in strains
35000HP and CIP 542 ATCC (Fig. 1). The GC content of the
dsrAII DNA sequences was 40%, consistent with the AT-rich
nature of Haemophilus spp. (3).
The deduced amino acid sequence of DsrAII predicted a
protein of 31,646 Da. A possible signal peptidase I cleavage
site was predicted to be LSA, unlike TMA in DsrAI from
35000HP (Fig. 3). Cleavage at this site would result in a mature
protein of 28,880 Da.
The predicted amino acid sequence of the DsrAII protein
was 47.8% identical and 56% similar to the DsrA protein of
strain 35000HP. An amino acid lineup of these two DsrA
proteins revealed significant variation in the N-terminal two-
thirds of the protein (Fig. 3). The DsrAII signal peptide (the
first 26 amino acids) from CIP 542 ATCC contained five MK
repeats, whereas DsrAI (35000HP) had only one copy of MK.
FIG. 2. Identification of antigenically variant DsrA proteins.
(A) Two identical SDS-PAGE gels were prepared under reducing
conditions with total cellular proteins from the indicated H. ducreyi
strains and subjected to Western blotting. Panel 1, DsrA expression is
detected using polyclonal anti-rFL-DsrAI made to rDsrAI from strain
35000HP; panel 2, DsrA expression is detected with MAb 4.79 made to
rDsrAI from strain 35000HP. (B) H. ducreyi strains were examined for
surface expression of class I and II DsrA in a dot blot format.
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Despite the diversity noted at the N terminus, the C terminus
was more highly conserved. The C-terminal sequence of class
I and class II DsrAs contained a short motif consisting of
alternating hydrophobic residues and ending with a phenylal-
anine, as is found in the majority of integral outer membrane
proteins (OMPs) (60, 66). The final 86 amino acids (Fig. 3)
were 88.5% identical and 89.7% similar in DsrAI and DsrAII.
Detection of variable DsrA expression in a panel of H. du-
creyi clinical isolates. The identification of an antigenically
variant DsrA in strain CIP 542 ATCC suggested that other
strains of H. ducreyi might also express an alternate form(s) of
DsrA. To examine this possibility, a panel of 19 geographically
and temporally diverse isolates (Table 2) was chosen for fur-
ther study. The panel of strains, including 35000HP (DsrAI)
and CIP 542 ATCC (DsrAII) controls, was subjected to SDS-
PAGE, followed by Western blotting with antibodies listed in
Table 3 (Fig. 4). All strains examined reacted with polyclonal
anti-rFL-DsrAI (Fig. 4, panel 1), albeit weakly by some, sug-
gesting shared epitopes among the DsrA proteins expressed by
these strains. However, when examined with the class-specific
sera elicited to the N-terminal two-thirds of each DsrA pro-
tein, strains were placed into one of two categories: H. ducreyi
strains that expressed a DsrAI protein or a DsrAII protein (Fig.
4, panels 2 and 3).
Strains HMC46, HMC56, and HMC60 reacted weakly with
anti-rFL-DsrAI but did not react with either anti-rNt-DsrAI or
anti-rNt-DsrAII sera (Fig. 4, panels 1 to 3). DNA sequencing
revealed that the dsrAs from these three strains were identical
(Table 5). Each strain contained two single nucleotide differ-
ences compared to strain 35000HP, one located between the
putative 	35 and 	10 regions and the other within the 	10
region of the promoter (data not shown). A comparison of
these dsrAs with eight previously analyzed H. ducreyi isolates
(19; data not shown) indicated that the predicted dsrA se-
quence from strain CHIA was identical to those of HMC46,
HMC56, and HMC60 (Table 5). Based on nucleotide se-
quences, we concluded that HMC46, HMC56, and HMC60
were class I strains despite their weak expression of DsrAI.
H. ducreyi strains DMC64, DMC111, SSMC71, and
HMC112 reacted with anti-rFL-DsrAI and anti-rNt-DsrAII,
but not with anti-rNt-DsrAI antisera (Fig. 4, panels 1 to 3).
Sequence comparison revealed that the dsrA genes from these
strains were 100% identical to each other. When these se-
quences were compared to the dsrA from strain 35000HP, only
48% identity was observed. From these limited studies, we
determined that the H. ducreyi strains studied here express
either DsrAI or DsrAII proteins, but not both.
Identification of two classes of NcaA, another member of the
Oca family from H. ducreyi. Some bacteria express more than
one Oca family member (48); hence, we examined H. ducreyi
35000HP for expression of additional Oca family proteins. A
search of the genome sequence of strain 35000HP (http://www
FIG. 3. Alignment of DsrAI and DsrAII amino acid sequences. The amino acid sequences of DsrA from 35000HP and DsrA from CIP 542
ATCC are compared. Boxed, shaded residues indicate identity. The first arrow indicates the possible signal peptidase I cleavage site; the second
arrow indicates the end of the protein that was used for antibody production. The final 86 amino acids of the C termini are underlined.
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.stdgen.lanl.gov/stdgen/bacteria/hduc/) revealed a second
member with weak similarity to DsrA (16% identity), termed
NcaA (for necessary for collagen attachment A) (HD1920)
(15).
To determine the prevalence of NcaA among DsrAI- and
DsrAII-expressing strains, the panel of 19 H. ducreyi strains was
examined in a Western blot with anti-rNt-NcaAI antiserum
(Fig. 4, panel 4). The NcaA antiserum primarily recognized the
oligomeric form (approximately 80 kDa) of the NcaA protein
from class I but did not recognize either the oligomeric or
FIG. 4. Identification of two classes of OMPs. Nine identically loaded SDS-PAGE gels (panels 1, 3, 6 and 7, 15% PAGE; panel 9, 12.5% PAGE;
panels 2 and 5, 12% PAGE; panels 4 and 8, 7.5% PAGE) were prepared under reducing conditions with total cellular proteins or crude LOS from
the indicated H. ducreyi strains and subjected to Western blotting, except for gel 9. Crude LOS in gel 9 was prepared as described in Materials and
Methods and subjected to silver staining after electrophoresis. The class of each strain is indicated at the bottom of the figure. N-terminal
antibodies were made to the N-terminal two-thirds of each recombinant protein (Table 3 and Fig. 1). Arrows indicate strains that reacted weakly
with the antisera against DsrAI protein.
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monomeric (approximately 33-kDa) form of class II strains.
Sequence comparison of NcaA from 35000HP (class I) and
CIP 542 ATCC (class II) revealed strongly conserved C ter-
mini, with little conservation within the N termini (Fig. 5). In
addition, a comparison of the NcaA sequence from CIP 542
ATCC with class II strains DMC64, DMC111, SSMC71, and
HMC112 showed 100% identity within class II. This finding
explained the lack of reactivity to class II NcaA with anti-rNt-
NcaAI, since this N-terminal region was the source of immuno-
gen used for antibody production of anti-rNcaAI (Fig. 5).
Taken together, these data demonstrate that H. ducreyi strains
express two Oca family members, DsrA and NcaA. Among
isolates tested thus far, strains expressing DsrAI also express
NcaAI, and those expressing DsrAII likewise express NcaAII.
Class I and class II strains express variants of other OMPs.
The detection of two antigenically diverse classes of DsrA and
NcaA proteins in a panel of H. ducreyi strains raised the pos-
sibility that class II strains may express different versions of
other outer membrane antigens. To test this possibility, the
panel of 19 H. ducreyi strains was subjected to Western blotting
and examined for expression of DltA (33), Hlp (for H. ducreyi
lipoprotein) (25), major OMP (MOMP) and OmpA2 (24, 31),
and HgbA (18, 59) (Fig. 4, panels 5 to 8). Leduc et al. (33)
recently described DltA, a novel lectin required for the full
expression of serum resistance phenotype in H. ducreyi strain
35000HP. Anti-rFL-DltA antiserum recognized DltA in all
strains tested, although DltAs from class II strains migrated
faster than DltAs from class I strains (Fig. 4, panel 5). Com-
parison of the predicted DltA sequences (Table 5) between
five class I and five class II strains revealed that the sequences
within each class were identical. However, comparison of the
DltA sequences from class II strains with that of strain
35000HP revealed four amino acid differences between the
classes: H25N, T40 M, R63H, and E74K (data not shown).
We next examined a Western blot of the 19 strains with an
anti-Hlp antibody (25) and MAb 2C7. A putative Hlp protein
was expressed in all isolates studied (Fig. 4, panel 6). However,
in class II strains, the putative Hlp protein migrated more
slowly than that of class I strains. MAb 2C7 was previously
shown to recognize the MOMP and OmpA2 homologs as three
bands with apparent molecular weights of 37, 39, and 43 kDa
on SDS-PAGE gels (57). However, Klesney-Tait et al. (31)
showed that depending on the SDS-PAGE system used, the
37- to 39-kDa bands may migrate as a single entity, resulting in
the formation of two bands on the gel. Whole-cell preparations
of H. ducreyi were subjected to SDS-PAGE with 15% PAGE to
separate and visualize the bands in the 37- to 39-kDa range
(Fig. 4, panel 7). Class I strains expressed only one or two of
the bands in the 37- to 39-kDa range in different intensities,
while only a single 2C7-reactive protein was recognized in all
class II strains. Furthermore, there was a subtle, consistent
mobility difference seen in the single band present in class II
FIG. 5. Alignment of NcaAI and NcaAII amino acid sequences. The amino acid sequences of the NcaA proteins from 35000HP and CIP 542
ATCC are compared. Boxed, shaded residues indicate identity. The predicted signal peptidase I cleavage site for 35000HP and CIP 542 ATCC
is indicated by the inverted triangle. The segment encompassed by the two arrows represents the N-terminal region of recombinant NcaAI from
35000HP that was used for antibody production.
2394 WHITE ET AL. INFECT. IMMUN.
strains (Fig. 4, panel 7). PCR of the five class II strains with
primers 3f12-3 and OmpA2-9, flanking the tandemly arranged
MOMP and OmpA2 genes (31), gave products similar in size
to those of 35000HP (data not shown). These data suggest that,
although both classes of H. ducreyi appear to contain similar
momp and ompA2 gene structures, expression of these proteins
is different in class II strains. The slight difference in the mo-
bility of MOMP and/or OmpA2 proteins seen in Western blots
(Fig. 4, panel 7) also suggests that there are sequence differ-
ences between class I and class II strains.
To examine the expression of the hemoglobin receptor,
HgbA, in H. ducreyi class I and class II strains, the panel of 19
strains was subjected to Western blotting with anti-rFL-HgbAI
serum (Fig. 4, panel 8). HgbA was recognized in all strains
tested. Sequence comparison of HgbA within class I strains
revealed 97% similarity, and those within class II strains were
99% similar. Comparisons between class I and class II strains
revealed 95.3% similarity (data not shown). These results sug-
gest minimal variability of the HgbA amino acid sequence
within or between class I and class II strains.
In addition to the OMPs, LOS was examined in these strains
by SDS-PAGE and silver staining. As shown in Fig. 4, panel 9,
LOS from class I strains, with the exception of strain C111,
exhibited a slower-migrating LOS than that of class II strains.
Based on the OMP and LOS expression patterns, these data
indicate that at least two classes of H. ducreyi exist among
isolates examined thus far.
DsrAII mediates serum resistance. It was previously shown
that DsrAI is required for the H. ducreyi serum resistance
phenotype (19). We determined that class II strains CIP 542
ATCC and HMC112 were also serum resistant, exhibiting
100% survival in 50% NHS (Fig. 6). In the absence of an
isogenic mutant, we tested the ability of cloned dsrAI and
dsrAII to confer serum resistance to the isogenic class I dsrA
mutant strain FX517 harboring pUNCH 1260 (dsrAI), pUNCH
1296 (dsrAII) and pLSKS (empty vector) (Fig. 6). Expression of
either dsrAI from pUNCH 1260 or dsrAII from pUNCH 1296
in host strain FX517 (the dsrAI mutant) conferred serum re-
sistance to FX517, resulting in 100% survival (P 
 0.017 and
P 
 0.001, respectively) (Fig. 6). In contrast, FX517 harboring
an empty vector exhibited 5% survival.
DISCUSSION
We propose that there are at least two distinct populations,
termed classes here, of H. ducreyi strains that express variant
forms of the OMPs DsrA, NcaA, DltA, Hlp, MOMP and/or
OmpA2, as well as LOS. This conclusion is based upon the
following evidence.
Findings. (i) The sequences of two Oca family members,
DsrA and NcaA, differ between the two classes of H. ducreyi
strains. Comparison of the N termini of the DsrAI and DsrAII
proteins revealed little sequence homology, while the C-termi-
nal domains were nearly identical (Fig. 3). Within the leader
sequence at the very N terminus of DsrAII were five MK
(ATGAAA) repeats, whereas only one copy of MK existed in
DsrAI (Fig. 3). The significance of this pentamer repeat is
unclear, although it is conceivable that it may be involved in
some form of phase variation resulting in an on/off phenotype
in these strains. Transcription of dsrAII is predicted to begin
with the first methionine (ATG) of the pentamer. Mutations
changing the use to other ATGs would affect the spacing be-
tween the ribosome-binding site and the start of the transla-
tion, resulting in decreased expression of the protein. Indeed,
such a mutation occurred in pUNCH 1288, which expresses
DsrAII protein weakly (data not shown). Conversely, muta-
tions may represent in vitro artifacts and additional studies are
necessary before any conclusions can be drawn.
Another noticeable difference between the DsrA protein
from H. ducreyi classes I and II was the presence of the hep-
FIG. 6. Bactericidal killing of strains expressing class I and II DsrA. Bactericidal killing of H. ducreyi strains was performed in 50% NHS. The
data are compiled from separate experiments done on at least three different days. The asterisk indicates statistically significant differences between
the FX517 dsrA strain (35000HP isogenic dsrAI mutant) containing the empty vector pLSKS and FX517 dsrA complemented in trans with vectors
expressing either dsrA class I (pUNCH 1260) or dsrA class II (pUNCH 1296) (P 
 0.017 and P 
 0.001, respectively). WT, wild type.
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tameric repeat sequence NTHNINK in the class I strains (19)
that was absent in the class II strains. We previously reported
that class I strains contained one, two, or three of these hep-
tameric repeats. The function of these repeats has yet to be
determined.
Cole et al. (15) recently described NcaAI, a protein neces-
sary for H. ducreyi binding to the ECM protein type I CN, in
strain 35000HP. In this study, we described NcaAII, a variant of
NcaAI, composed of a divergent N terminus but a highly con-
served C-terminal domain. NcaAI was recently shown to be a
virulence factor in the swine model of chancroid (15). Loss of
NcaA expression in an isogenic mutant resulted in the decrease
of the number of H. ducreyi culture-positive lesions and CFU
recovered per lesion on day 7 of infection. Future studies need
to be conducted to determine if NcaAII, like NcaAI, binds CN
and whether NcaAII is important for virulence in these strains.
(ii) The sequence of the H. ducreyi lectin, DltA, differs be-
tween class I and class II strains. Recently, our laboratory
described a novel lipoprotein lectin, termed DltA, found in H.
ducreyi strain 35000HP and involved in serum resistance (33).
In this study, we determined that all strains tested express DltA
and that class II strains possess a variant form of DltA that
migrates at a different molecular weight in Western blots than
does DltA from class I strains. When DltA was examined at the
DNA and the predicted amino acid levels (Table 5), four
conserved predicted amino acid differences were observed be-
tween the two classes of H. ducreyi strains, likely accounting for
the variable mobility seen in Western blots (Fig. 4, panel 5).
(iii) Hlp protein migration differences. There was a differ-
ence in migratory patterns in putative Hlp proteins, since Hlp
from class II isolates migrated slower on SDS-PAGE than class
I strains (Fig. 4, panel 6). Furthermore, the anti-Hlp antibody
reacted weakly to the Hlp in class II strains even though all
wells were loaded equally. More studies are needed to deter-
mine if differences at the sequence or expression level or in
lipidation pattern are responsible for these differences.
(iv) MOMP/OmpA2 migration differences. The H. ducreyi
MOMP (24), comprises two homologs, MOMP and OmpA2.
Spinola et al. (57) previously showed that both proteins are
recognized by MAb 2C7. In this study, we demonstrated that
MAb 2C7 recognized MOMP and/or OmpA2 from class I
strains as one or two distinct bands in Western blots while only
one, more slowly migrating band was detected in class II
strains. Furthermore, MAb 2C7 reacted only weakly to the
single band present in class II strains (Fig. 4, panel 7). Future
studies may determine which, if either, of the two proteins is
not expressed in the class II strains and whether differences
exist within the momp and ompA2 gene sequences between
strain classes.
(iv) Class I and class II strains express different species of
LOS. LOS may be a possible virulence factor for H. ducreyi and
may play a role in pathogenesis of chancroid (12). Our studies
have shown that class I strains, with the exception of C111,
contain a slower-migrating LOS species typical of strain
35000HP. In contrast, class II LOS species migrate faster than
35000HP (Fig. 4, panel 8). Despite the difference in mobility of
the LOS species, the class II strains CIP 542 ATCC and
HMC112, expressing faster-migrating LOS, are as resistant to
serum killing as 35000HP (Fig. 6). In support of these findings,
our laboratory has determined that LOS mutants 35.252 (7)
and 35.10 (6) (parent strain 35000HP), expressing severely
truncated forms of LOS, resist killing in a bactericidal assay
with 50% NHS (unpublished data). During the preparation of
the manuscript, Scheffler et al. (51) analyzed the proteome of
several strains of H. ducreyi that vary in their LOS structure by
two-dimensional gel electrophoresis and mass spectrometry.
They concluded that little proteome diversity existed in rela-
tion to the LOS of each strain. One exception, strain 33921,
showed significant differences in its proteome map and synthe-
sized an unusual LOS with a trisaccharide branch structure.
Scheffler et al. (51) concluded that the studies did not preclude
the possibility that significant variations exist among the pro-
teomes of the strains tested. The differences seen with strain
33921 may suggest that this strain belongs to the second clonal
population of H. ducreyi described here. Studies are under way
to determine if strain 33921 is a class II strain.
Implications of two clonal populations of H. ducreyi. In this
report, we presented evidence that two major classes of H.
ducreyi strains exist. In the course of this study, we observed
that class II strains, CIP 542 ATCC and HMC112, grew more
slowly than most class I strains and formed smaller colonies on
solid medium (data not shown). These observations raised the
possibility that the poor isolation rate of H. ducreyi from pri-
mary lesions (38) may in part be due to these differences in
growth characteristics. Most importantly, class II strains may
be markedly underrepresented in current culture collections
compared to their presence in ulcers. Additional information is
needed to address this concern.
PCR has been shown to be a more sensitive method of
detection than culture (38). Our primer pairs, dsrA 14-dsrA 24,
dsrA 42-dsrA 43, ncaA 0.08-ncaA 0.09, and ncaA 0.10-ncaA 0.11
(Table 4), are specific for either class I or class II dsrA or ncaA
and may be useful in discriminating between an H. ducreyi class
I- or class II-infected lesion. However, these primers have yet
to be proven with material from primary lesions.
The discovery of two populations of H. ducreyi raises issues
about vaccine development against chancroid. Several OMPs
such as DsrA, NcaA, MOMP, hemolysin (43, 67), D15 (65),
and HgbA have been suggested as possible vaccine candidates.
The hemoglobin-binding OMP HgbA, also termed HupA (59),
is a 100-kDa protein essential to the ability of H. ducreyi to
utilize both hemoglobin and hemoglobin-haptoglobin as
sources of heme (59). HgbA is also required for expression of
full virulence in the temperature-dependent rabbit model (59)
and the human model of chancroid (5). Patterson et al. (44)
reported that HgbA was highly conserved, since three anti-
HgbA Mabs bound to all 26 strains tested. The sole exception
was MAb 4.23, which bound all strains except HMC112, iden-
tified as a class II strain in the present study. Here, we deter-
mined that the amino acid sequences of hgbA were strikingly
similar between class I and class II strains, considering the
degree of variability found in the Oca proteins. The high de-
gree of hgbA sequence conservation between the classes sug-
gests that a protective vaccine containing HgbA from either
class I or class II may be efficacious against both classes. How-
ever, it is unclear if a monovalent vaccine designed against
more variable H. ducreyi targets will be capable of inducing
protection against both class I and class II strains.
DsrAI and DsrAII have similar functions. Elkins et al. (19)
previously showed that DsrAI expression was essential for the
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full serum resistance phenotype in nine strains of H. ducreyi.
Serum resistance is an important virulence factor for H. du-
creyi, since serum susceptible strains are avirulent (9, 40, 42). In
the human infection model of chancroid, Bong et al. (9) dem-
onstrated that inoculation with strains 35000HP and FX517
(the dsrAI mutant) resulted in the formation of papules. How-
ever, only subjects who received strain 35000HP developed
infections that progressed to the pustular stage of infection. In
this report, we demonstrated that both classes of DsrA pro-
teins conferred serum resistance to type strains 35000HP (19)
and CIP 542 ATCC in high concentrations of NHS (50%).
Based on these observations, it is possible that inoculation with
strains expressing DsrAII in the human model of chancroid
may result in an infection similar to that observed with strain
35000HP. Studies are needed to confirm this hypothesis. These
findings also suggest that the functional domains involved in
serum resistance are possibly conserved within the C termini of
both DsrAI and DsrAII proteins. Current studies will deter-
mine the specific sequences responsible for the serum resis-
tance phenotypes, if DsrAII, like DsrAI, is involved in attach-
ment to keratinocytes and ECM proteins, and whether DsrAII
is important for virulence in the animal and human models of
chancroid.
In conclusion, the discovery of variant forms of important
OMP constituents in strains isolated from Africa and Asia over
a period of decades provides strong evidence that two clonal
populations of H. ducreyi exist. This data may strongly impact
our understanding of the pathogenesis of chancroid, disease
diagnosis, treatment, and vaccine development.
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TABLE 4. List of primers used in this study
Name Class Sequencea Reference or source
dsrA 14 I GACAGCATTCAGTGAATAATGGC 19
dsrA 19 I ATTAATGCAGCAGCCGCCAAAGTTTGCTGG This study
dsrA 20 I GCGGCCGCGAATTCATACCCAACAGAACCACC This study
dsrA 24 I and II AATGAAGTCCGCACCTTTAACGGC 19
dsrA 33 II CATCGTCGAACGCACACTG This study
dsrA 36 II ATGCAGATGCAACCGCAAAATTTTG This study
dsrA 37 II CGTGTTTTTAAAGATGTCAGC This study
dsrA 38 I ATGCAGCAGCCGCCAAAGTTTGC This study
dsrA 39 I TGTATTTTGTTCCATCATACG This study
dsrA 42 II ctaggtctagaTGCCTTGCTCTTAATGACG This study
dsrA 43 II gcccaagcttTAAAAGCACATAAACAAGCG This study
ncaA 0.01 I GAATTATTTTAAGCCAATTTTTTTGC This study
ncaA 0.02 I CCACATCCGAAACATATATTAAAGTTAATT This study
ncaA 0.05 I TTATTGAAAATTATATACAAAGCCTACACC This study
ncaA 0.08 I ATGAAATCAGATACGCTGAGTAAGG This study
ncaA 0.09 I ATTTGCAGTAGTTGCTCCGCGTCC This study
ncaA 0.10 II GGTTGATTATGTCGAATAATTTG This study
ncaA 0.11 II CTAAGCGCGTAAAAATTCGATG This study
DLTA.01 I CGCTTGTACAAGCGGGC 33
DLTA.02 I CAGCTTACAAAATGATGGGC 33
hgbA-F II AGCGATTACTCTCTGTATTTTGGGG This study
hgbA-R II GCAGATATTGCTGCATCATCGGAG This study
hgbA 2 I TTAATGCAGGGCCTGCGTTAAAGC This study
hgbA 3 I TTAGCCGTACACACCCAAC This study
hgbA 4 I CCTACTTTGCTACTCATTCTGCC This study
hgbA 5 I CTAACCCTTCTGGGCTATAC This study
hgbA 8 I CGCGCCTGTTTTAGTTTTAACTGG This study
hgbA 9 I GCAGTGGTGGGCAAATATC This study
hgbA 10 I GCTAGGTAAATACACACGGC This study
hgbA 12 I CGTCCTTTGAGTTAAAGTGG This study
hgbA 13 I TCAACCTCAAACGCATGTGGTTGGG This study
hgbA 17 I GCATCCTTCGTTCTCGATTT This study
hgbA 18 I GTACGGCTAACAAATCAAAA This study
hgbA 21 I CATCCGTTCTATCCGCCCG This study
3fl2-3 I CCAATTATCTCCTATTGC Fig. 2 in reference 31
OmpA2-9 I GCGATAAATCACTCTTAACCCGAC Fig. 2 in reference 31
a Lowercase letters indicate a non-H. ducreyi sequence. Underlined sequences are XbaI and HindIII sites, respectively.
TABLE 5. GenBank accession numbers for relevant DNA
sequences presented in this study
Strain
Accession no. or reference for:
DsrA DltA NcaA HgbA
35000HP 19 AY371540 15 18
HMC46 AY606124 NSa NS AY606118
HMC56 AY606125 AY371542 NS AY606119
HMC60 AY606126 NS NS AY606117
C111 NS NS NS AY603049
CIP 542 ATCC AY606123 AY371545 AY606129 AY606114
DMC64 AY606121 AY371546 AY612646 AY606115
DMC111 AY612644 AY371547 AY612645 AY603046
SSMC71 AY606120 AY371548 AY606128 AY603048
HMC112 AY606122 AY371549 AY498730 AY603047
a NS, not sequenced.
VOL. 73, 2005 TWO CLONAL POPULATIONS OF H. DUCREYI 2397
son, and Stanley Spinola for providing H. ducreyi strains, plasmids, and
antibodies. Furthermore, we thank Robert S. Munson for providing
the sequence of H. ducreyi strain 35000HP, Chris Thomas for help with
figures and DNA analysis, and members of the Infectious Diseases
Research Laboratory for reviewing the manuscript and providing in-
valuable suggestions. We especially thank Tom Kawula and Leah Cole
for careful review of the manuscript and helpful suggestions. We also
thank Walter E. Bollenbacher and Leslie Lerea for their ongoing
support and encouragement.
This work was supported by grants AI 31496, R01-AI 53593-02 to
C.E. and the Minority Opportunities in Research Division of the
National Institute of General Medical Sciences grant GM000678.
C.D.W. is currently a fellow in the Seeding Postdoctoral Innovators in
Research and Education (SPIRE) program.
REFERENCES
1. Aebi, C., E. R. Lafontaine, L. D. Cope, J. L. Latimer, S. L. Lumbley, G. H.
McCracken, Jr., and E. J. Hansen. 1998. Phenotypic effect of isogenic uspA1
and uspA2 mutations on Moraxella catarrhalis 035E. Infect. Immun. 66:3113–
3119.
2. Aebi, C., I. Maciver, J. L. Latimer, L. D. Cope, M. K. Stevens, S. E. Thomas,
G. H. McCracken, Jr., and E. J. Hansen. 1997. A protective epitope of
Moraxella catarrhalis is encoded by two different genes. Infect. Immun. 65:
4367–4377.
3. Albritton, W. L. 1989. Biology of Haemophilus ducreyi. Microbiol. Rev.
53:377–389.
4. Alfa, M. J., and P. DeGagne. 1997. Attachment of Haemophilus ducreyi to
human foreskin fibroblasts involves LOS and fibronectin. Microb. Pathog.
22:39–46
5. Al-Tawfiq, J. A., K. R. Fortney, B. P. Katz, A. F. Hood, C. Elkins, and S. M.
Spinola. 2000. An isogenic hemoglobin receptor-deficient mutant of Hae-
mophilus ducreyi is attenuated in the human model of experimental infection.
J. Infect. Dis. 181:1049–1054.
6. Bauer, B. A., S. R. Lumbley, and E. J. Hansen. 1999. Characterization of a
WaaF (RfaF) homolog expressed by Haemophilus ducreyi. Infect. Immun.
67:899–907.
7. Bauer, B. A., M. K. Stevens, and E. J. Hansen. 1998. Involvement of the
Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression
and virulence. Infect. Immun. 66:4290–4298.
8. Bong, C. T., M. E. Bauer, and S. M. Spinola. 2002. Haemophilus ducreyi:
clinical features, epidemiology, and prospects for disease control. Microbes
Infect. 4:1141–1148.
9. Bong, C. T., R. E. Throm, K. R. Fortney, B. P. Katz, A. F. Hood, C. Elkins,
and S. M. Spinola. 2001. DsrA-deficient mutant of Haemophilus ducreyi is
impaired in its ability to infect human volunteers. Infect. Immun. 69:1488–
1491.
10. Bozue, J. A., L. Tarantino, and R. S. Munson, Jr. 1998. Facile construction
of mutations in Haemophilus ducreyi using lacZ as a counter-selectable
marker. FEMS Microbiol. Lett. 164:269–273.
11. Brentjens, R., M. Ketterer, M. Apicella, and S. Spinola. 1996. Fine tangled
pili expressed by Haemophilus ducreyi are a novel class of pili. J. Bacteriol.
178:808–816.
12. Campagnari, A. A., L. M. Wild, G. E. Griffiths, R. J. Karalus, M. A. Wirth,
and S. M. Spinola. 1991. Role of lipooligosaccharides in experimental der-
mal lesions caused by Haemophilus ducreyi. Infect. Immun. 59:2601–2608.
13. Carbonetti, N., V. Simnad, C. Elkins, and P. F. Sparling. 1990. Construction
of isogenic gonococci with variable porin structure: effects on susceptibility
to human serum and antibiotics. Mol. Microbiol. 4:1009–1018.
14. Cole, L. E., T. H. Kawula, K. L. Toeffer, and C. Elkins. 2002. The Haemophi-
lus ducreyi serum resistance antigen, DsrA, binds vitronectin and confers
attachment to human keratinocytes. Infect. Immun. 70:6158–6165.
15. Cole, L. E., R. A. Fulcher, K. L. Toffer, P. E. Orndorff, C. Elkins, and T. H.
Kawula. Expression of Haemophilus ducreyi outer membrane protein NcaA
is required for collagen I binding and virulence in swine model of chancroid,
submitted for publication.
16. Comanducci, M., S. Bambini, B. Brunelli, J. Adu-Bobie, B. Arico, B. Capec-
chi, M. M. Giuliani, V. Masignani, L. Santini, S. Savino, D. M. Granoff, D. A.
Caugant, M. Pizza, R. Rappuoli, and M. Mora. 2002. NadA, a novel vaccine
candidate of Neisseria meningitidis. J. Exp. Med. 195:1445–1454.
17. DiCarlo, R. P., and D. H. Martin. 1997. The clinical diagnosis of genital ulcer
disease in men. Clin. Infect. Dis. 25:292–298.
18. Elkins, C. 1995. Identification and purification of a conserved heme-regu-
lated hemoglobin-binding outer membrane protein from Haemophilus du-
creyi. Infect. Immun. 63:1241–1245.
19. Elkins, C., K. J. Morrow, Jr., and B. Olsen. 2000. Serum resistance in
Haemophilus ducreyi requires outer membrane protein DsrA. Infect. Immun.
68:1608–1619.
20. Elkins, C., K. Yi, B. Olsen, C. Thomas, K. Thomas, and S. Morse. 2000.
Development of a serological test for Haemophilus ducreyi for seropreva-
lence studies. J. Clin. Microbiol. 38:1520–1526.
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